Press Releases

Nov 21, 2023

Syros to Participate in Upcoming Investor Conferences

Nov 14, 2023

Syros Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Nov 7, 2023

Syros to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

Oct 2, 2023

Syros Announces Planned CEO Leadership Transition and Strategic Reorganization to Support Long-Term Business Growth and Maturation into a Commercial Biopharmaceutical Company

Sep 7, 2023

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 8, 2023

Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

Aug 4, 2023

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 1, 2023

Syros to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Jul 5, 2023

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 8, 2023

Syros to Present at Sidoti June 2023 Virtual Small-Cap Conference